title: ÐÑÐµÐ½ÐºÐ° ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ñ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸, ÑÑÐ½ÐºÑÐ¸Ð¾Ð½Ð¸ÑÑÑÑÐµÐ¹ Ð½Ð° Ð¼Ð¸ÑÐ¾Ð²Ð¾Ð¼ ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¾Ð¼ ÑÑÐ½ÐºÐµ
title: Ð²ÑÐ¿ÑÑÐºÐ½Ð°Ñ ÐºÐ²Ð°Ð»Ð¸ÑÐ¸ÐºÐ°ÑÐ¸Ð¾Ð½Ð½Ð°Ñ ÑÐ°Ð±Ð¾ÑÐ° Ð±Ð°ÐºÐ°Ð»Ð°Ð²ÑÐ°
titleType: Subtitle
title: Assessment of the financial condition of a company operating in the global pharmaceutical market
Creators: name: ÐÐ°Ð½ ÐÑÐ¹Ð¸Ð½
Publisher: name: Ð¡Ð°Ð½ÐºÑ-ÐÐµÑÐµÑÐ±ÑÑÐ³ÑÐºÐ¸Ð¹ Ð¿Ð¾Ð»Ð¸ÑÐµÑÐ½Ð¸ÑÐµÑÐºÐ¸Ð¹ ÑÐ½Ð¸Ð²ÐµÑÑÐ¸ÑÐµÑ ÐÐµÑÑÐ° ÐÐµÐ»Ð¸ÐºÐ¾Ð³Ð¾
Year: 2022
Subjects: ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¸Ð¹ ÑÑÐ½Ð¾Ðº
ÑÐ½Ðº
ÑÐ°Ð½Ð¾ÑÐ¸
ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ðµ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ðµ
pharmaceutical market
tnc
sanofi
financlal state

description: Ð¢ÐµÐ¼Ð° ÐÐÐ : Â«ÐÑÐµÐ½ÐºÐ° ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ñ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸, ÑÑÐ½ÐºÑÐ¸Ð¾Ð½Ð¸ÑÑÑÑÐµÐ¹ Ð½Ð° Ð¼Ð¸ÑÐ¾Ð²Ð¾Ð¼ ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¾Ð¼ ÑÑÐ½ÐºÐµÂ». Ð Ð°Ð±Ð¾ÑÐ° Ð¿Ð¾ÑÐ²ÑÑÐµÐ½Ð° Ð¸ÑÑÐ»ÐµÐ´Ð¾Ð²Ð°Ð½Ð¸Ñ ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ñ Ð¾Ð´Ð½Ð¾Ð¹ Ð¸Ð· ÐºÑÑÐ¿Ð½ÐµÐ¹ÑÐ¸Ñ Ð¢ÐÐ ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¾Ð³Ð¾ ÑÑÐ½ÐºÐ°, Ð² ÑÐ¾Ð¼ ÑÐ¸ÑÐ»Ðµ Ð² ÑÐ¿ÐµÑÐ¸ÑÐ¸ÑÐµÑÐºÐ¸Ñ ÑÑÐ»Ð¾Ð²Ð¸ÑÑ Ð¿Ð°Ð½Ð´ÐµÐ¼Ð¸Ð¸. ÐÐ°Ð´Ð°ÑÐ¸, ÐºÐ¾ÑÐ¾ÑÑÐµ ÑÐµÑÐ°Ð»Ð¸ÑÑ Ð² ÑÐ¾Ð´Ðµ Ð¸ÑÑÐ»ÐµÐ´Ð¾Ð²Ð°Ð½Ð¸Ñ: ÐÐ·ÑÑÐµÐ½Ð¸Ðµ Ð¼Ð¸ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¾Ð³Ð¾ ÑÑÐ½ÐºÐ°; ÐÑÑÐ²Ð»ÐµÐ½Ð¸Ðµ Ð¾ÑÐ½Ð¾Ð²Ð½ÑÑ Ð¸Ð³ÑÐ¾ÐºÐ¾Ð² Ð¼Ð¸ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¾Ð³Ð¾ ÑÑÐ½ÐºÐ°; ÐÐ½Ð°Ð»Ð¸Ð· Ð¼ÐµÐ¶Ð´ÑÐ½Ð°ÑÐ¾Ð´Ð½Ð¾Ð¹ ÑÐ¾Ð·ÑÐ¹ÑÑÐ²ÐµÐ½Ð½Ð¾Ð¹ Ð´ÐµÑÑÐµÐ»ÑÐ½Ð¾ÑÑÐ¸ ÐºÑÑÐ¿Ð½Ð¾Ð¹ ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¾Ð¹ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸; ÐÐ½Ð°Ð»Ð¸Ð· ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ñ ÐºÑÑÐ¿Ð½Ð¾Ð¹ ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¾Ð¹ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸; Ð Ð°Ð·ÑÐ°Ð±Ð¾ÑÐºÐ° ÑÐµÐºÐ¾Ð¼ÐµÐ½Ð´Ð°ÑÐ¸Ð¹ Ð¿Ð¾ ÑÐ¾Ð²ÐµÑÑÐµÐ½ÑÑÐ²Ð¾Ð²Ð°Ð½Ð¸Ñ ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ñ ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¾Ð¹ Ð¢ÐÐ; Ð Ð°Ð±Ð¾ÑÐ° Ð¿ÑÐ¾Ð²ÐµÐ´ÐµÐ½Ð° Ð½Ð° Ð¾ÑÐ½Ð¾Ð²Ðµ Ð±ÑÑÐ³Ð°Ð»ÑÐµÑÑÐºÐ¾Ð¹ Ð¸ ÑÑÐ°ÑÐ¸ÑÑÐ¸ÑÐµÑÐºÐ¾Ð¹ Ð¸Ð½ÑÐ¾ÑÐ¼Ð°ÑÐ¸Ð¸ ÐºÑÑÐ¿Ð½ÐµÐ¹ÑÐ¸Ñ ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¸Ñ ÑÑÐ°Ð½ÑÐ½Ð°ÑÐ¸Ð¾Ð½Ð°Ð»ÑÐ½ÑÑ ÐºÐ¾ÑÐ¿Ð¾ÑÐ°ÑÐ¸Ð¹, Ð²ÑÐ¾Ð´ÑÑÐ¸Ñ Ð² Ð¢ÐÐ-10, ÑÐ°Ðº Ð½Ð°Ð·ÑÐ²Ð°ÐµÐ¼ÑÑ, Big Pharma, Â Ñ ÑÐµÐ»ÑÑ Ð¸Ð·ÑÑÐµÐ½Ð¸Ñ Ð¼Ð¸ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ°ÑÐ¼Ð°ÑÐµÐ²ÑÐ¸ÑÐµÑÐºÐ¾Ð³Ð¾ ÑÑÐ½ÐºÐ°. ÐÑÐ»Ð¸ Ð¿ÑÐ¾Ð²ÐµÐ´ÐµÐ½ Ð°Ð½Ð°Ð»Ð¸Ð·, ÑÐ°ÑÐ°ÐºÑÐµÑÐ¸Ð·ÑÑÑÐ¸Ð¹ Ð¿Ð¾Ð»Ð¾Ð¶ÐµÐ½Ð¸Ðµ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¹ Ð½Ð° ÑÑÐ½ÐºÐµ Ð¸ Ð¿ÑÐ¾Ð²ÐµÐ´ÐµÐ½Ñ ÑÐ°ÑÑÐµÑÑ Ð¿Ð¾ÐºÐ°Ð·Ð°ÑÐµÐ»ÐµÐ¹ ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ñ. Ð ÑÐ°ÑÑÐ½Ð¾ÑÑÐ¸, Ð±Ð¾Ð»ÐµÐµ Ð¿Ð¾Ð´ÑÐ¾Ð±Ð½ÑÐ¹ Ð°Ð½Ð°Ð»Ð¸Ð· ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ñ Ð¿ÑÐ¾Ð²ÐµÐ´ÐµÐ½ Ð½Ð° Ð¿ÑÐ¸Ð¼ÐµÑÐµ ÑÑÐ°Ð½ÑÑÐ·ÑÐºÐ¾Ð¹ Ð¢ÐÐ Â«SanofiÂ». ÐÐ½Ð°Ð»Ð¸Ð· Ð¿ÑÐ¾Ð²Ð¾Ð´Ð¸Ð»ÑÑ Ð² ÑÐ¾Ð¾ÑÐ²ÐµÑÑÑÐ²Ð¸Ð¸ Ñ Ð¾Ð±ÑÐµÐ¿ÑÐ¸Ð½ÑÑÐ¾Ð¹ Ð¼ÐµÑÐ¾Ð´Ð¸ÐºÐ¾Ð¹ ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ñ. Ð ÑÐµÐ·ÑÐ»ÑÑÐ°ÑÐµ Ð±ÑÐ»Ð¾ Ð¾ÑÐµÐ½ÐµÐ½Ð¾ ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ðµ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ðµ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸ Â«SanofiÂ», Ð²ÑÑÐ²Ð»ÐµÐ½Ñ Ð¾ÑÐ½Ð¾Ð²Ð½ÑÐµ Ð¿ÑÐ¾Ð±Ð»ÐµÐ¼Ñ Ð¸ ÑÐ°Ð·ÑÐ°Ð±Ð¾ÑÐ°Ð½Ñ ÑÐµÐºÐ¾Ð¼ÐµÐ½Ð´Ð°ÑÐ¸Ð¸ Ð¿Ð¾ ÑÑÐºÐ¾ÑÐµÐ½Ð¸Ñ Ð¾Ð±Ð¾ÑÐ°ÑÐ¸Ð²Ð°ÐµÐ¼Ð¾ÑÑÐ¸ Ð¾Ð±Ð¾ÑÐ¾ÑÐ½Ð¾Ð³Ð¾ ÐºÐ°Ð¿Ð¸ÑÐ°Ð»Ð°, Ð¾ÐºÐ°Ð·ÑÐ²Ð°ÑÑÐµÐ³Ð¾ Ð²Ð»Ð¸ÑÐ½Ð¸Ðµ Ð½Ð° ÑÐ»ÑÑÑÐµÐ½Ð¸Ðµ ÑÐ¸Ð½Ð°Ð½ÑÐ¾Ð²Ð¾Ð³Ð¾ ÑÐ¾ÑÑÐ¾ÑÐ½Ð¸Ñ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸.Â 
description: GQP theme: "Assessment of the financial condition of a company operating in the global pharmaceutical market". The work is devoted to the study of the financial condition of one of the largest TNCs in the pharmaceutical market, including in the specific conditions of a pandemic.Tasks that were solved in the course of the study: 1. Studying the global pharmaceutical market. 2. Identification of the main players in the global pharmaceutical market. 3. Analysis of the international economic activity of a large pharmaceutical company. 4. Analysis of the financial condition of a large pharmaceutical company. 5. Development of recommendations for improving the financial condition of a pharmaceutical TNC. The work was carried out on the basis of accounting and statistical information of the largest pharmaceutical transnational corporations included in the TOP-10, the so-called Big Pharma, in order to study the global pharmaceutical market. An analysis was carried out characterizing the position of companies in the market and calculations of indicators of financial condition were carried out. In particular, a more detailed analysis of the financial condition was carried out on the example of the French TNC Sanofi. The analysis was carried out in accordance with the generally accepted method of financial condition. As a result, the financial condition of Sanofi was assessed, the main problems were identified and recommendations were developed to accelerate the turnover of working capital, which has an impact on improving the financial condition of the company.Â Â Â